Gradient Investments »

Freeline Therapeutics Holdings shares owned by Gradient Investments

Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by Gradient Investments from 13F filings

Historical chart of Gradient Investments investment in Freeline Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Freeline Therapeutics Holdings held by Gradient Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Freeline Therapeutics Holdings by Gradient Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $637 100 6.37

More positions owned by Gradient Investments

Spdr Ser Tr Portfolio S&p500 (SPLG)
Innovator Etfs Trust Gradient Tactic (IGTR)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Doubleline Etf Trust Mortgage Etf (DMBS)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Innovator Etfs Trust Us Eqty Bufr Feb (BFEB)
Microsoft Corporation (MSFT)
Innovator Etfs Trust Us Eqty Pwr Buf (PFEB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Goldman Sachs Etf Tr Future Consumer (GBUY)
Ssga Active Etf Tr Ult Sht Trm Bd (ULST)
Apple (AAPL)

View all positions for Gradient Investments

Top funds holding Freeline Therapeutics Holdings

UBS Group
Blue Owl Capital Holdings
Jpmorgan Chase & Co
PenderFund Capital Management
Harbor Capital Advisors
Sphera Funds Management
Rhumbline Advisers

View all funds holding Freeline Therapeutics Holdings